Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.84 EUR | -2.75% | -11.75% | +27.78% |
12/04 | Global markets live: BP, Apple, Vodafone, Ford, Lockheed Martin... | |
12/04 | NFL Biosciences: successful capital increase | CF |
Sales 2023 | 200K 214K 17.82M | Sales 2024 * | - | Capitalization | 14.92M 15.98M 1.33B |
---|---|---|---|---|---|
Net income 2023 * | - | Net income 2024 * | - | EV / Sales 2023 | 74.6 x |
Net cash position 2023 * | 2.3M 2.46M 205M | Net cash position 2024 * | 200K 214K 17.82M | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 68.13% |
1 day | -2.75% | ||
1 week | -11.75% | ||
Current month | -33.21% | ||
1 month | -33.21% | ||
3 months | +16.46% | ||
6 months | +84.00% | ||
Current year | +27.78% |
Managers | Title | Age | Since |
---|---|---|---|
Bruno Lafont
FOU | Founder | - | 01/06/01 |
Ignacio Faus
CEO | Chief Executive Officer | - | 19/21/19 |
Guillaume Audema
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yannick Plétan
BRD | Director/Board Member | - | 19/21/19 |
Ignacio Faus
CEO | Chief Executive Officer | - | 19/21/19 |
Bruno Lafont
FOU | Founder | - | 01/06/01 |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 1.84 | -2.75% | 43,502 |
29/24/29 | 1.892 | +3.96% | 29,139 |
26/24/26 | 1.82 | -7.61% | 118,183 |
25/24/25 | 1.97 | -4.37% | 93,417 |
24/24/24 | 2.06 | -5.07% | 85,859 |
Real-time Euronext Paris, April 30, 2024 at 08:39 pm IST
More quotesChiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.78% | 15.95M | |
-1.17% | 102B | |
+2.87% | 96.09B | |
+2.13% | 22.28B | |
-14.77% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.21% | 16.09B | |
+8.55% | 13.83B | |
+35.75% | 11.97B |
- Stock Market
- Equities
- ALNFL Stock